TGen study allows late-stage cancer patients to use their health data to guide care

A unique study pairing researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, with one cancer patient is now underway to help answer that question. Rick Stanton, a former engineer and advanced prostate cancer patient, is at the center of TGen’s Patient Engagements, Operational Practices, and Laboratory Environment Standardization (PEOPLES) protocol.

Faces + Spaces @ TGen

Meet the rest of the PBC community through our monthly Faces and Spaces networking event. Each month join a small group of staff, researchers and community members from around the PBC to learn about a new area of the campus, upcoming programming and other exciting things happening right in your neighborhood. Grab a cup of coffee and collaborate! This event will introduce the Translational Genomics Research Institute, or TGen, an affiliate of the City of Hope. TGen was established in 2002 through an assembly of more than fifty leaders and visionaries in science, medicine, government and business by Dr. Jeffrey Trent. Today, it is a foundational company in the PBC and is a leader in translational research in the areas of cancer, neurological disorders, rare childhood disorders, and pathogen and microbome work.